Fact CheckerSign in

NCT05024292Recruiting

Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment

Oriental Research Alliance of Acute Ischemic Stroke Given Endovascular Treatment: Technique Feasibility, Safety and Neuroprotective Effects of in Situ Ischemic Postconditioning in Patients Underwent Successful Endovascular Thrombectomy

Source: ClinicalTrials.gov · Last updated 12 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.

Status (registry)
Recruiting
Study type
Observational
Enrollment
160 (estimated)
First submitted
22 Aug 2021
Start date
1 Jan 2022
Primary completion date
31 Dec 2026
Lead sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Diseases
Stroke
NCT number
NCT05024292

What you commit to

  • Study type: Observational
  • Planned participants: 160
  • From 1 Jan 2022 to the primary completion date, 31 Dec 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Stoke of large artery atherosclerotic origin or other determined factors (such as dissection) or tandem occlusion;
  • Patients underwent rescue angioplasty or stenting after thrombectomy

Who the study is looking for

  • Adult (age ≥ 18 to 95 years) patients with an occlusion of the internal carotid artery or M1 or M2 segment of the middle cerebral artery,;
  • Patients with a score of at least 6 on the National Institutes of Health Stroke Scale (NIHSS) at admission and a score of 0 or 1 on the modified Rankin scale before the onset of stroke;
  • Patients with a score of at least 6 on the Alberta Stroke Program Early CT score (ASPECTS) value;
  • Baseline multimodal-CT imaging, including NCCT, CTA and CTP, performed at the trial-site hospital
  • The modified thrombolysis in cerebral infarction (mTICI) scale 2b to 3 achieved in the infarct-related artery after the last thrombectomy attempt

Age in the registry: 18 years to 95 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting
Zhangzhou Municipal Hospital of Fujian Province
Coordinator of this site? Confirm its status
ZhangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.